Automatic Data Processing Inc vs Cassava Sciences Inc — how do they compare? Automatic Data Processing Inc trades at $269.5 (market cap $108.72B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Automatic Data Processing Inc is far larger — about 2276.9× Cassava Sciences Inc's market cap, and Automatic Data Processing Inc pays a 2.48% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| ADP | FLNA | |
|---|---|---|
Market Cap | $108.72B | $47.75M |
Sector | Industrials | Health |
52-Week High | $309.03 | $4.64 |
52-Week Low | $188.79 | $0.87 |
Enterprise Value | $109.76B | -$34.93M |
Dividend Yield | 2.48% | — |
Signals from Pluang's Aura AI — not financial advice
ADP trades at $271.32, down 0.8% for the day, with strong technical momentum showing bullish moving averages and key support at $269. The company demonstrates robust fundamentals with consistent earnings beats, 20.11% net margins, and 72.24% ROE. Recent Q4 2026 results showed 7% revenue growth and 17% EPS growth, driving positive analyst sentiment despite elevated valuation multiples.
Outlook remains positive with a $280.50 consensus price target offering 3.4% upside potential. Key opportunities include margin expansion and dividend stability, while risks center on high valuation sensitivity and labor market volatility affecting ADP's payroll processing business. The stock presents a quality growth opportunity with disciplined risk management required.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
ADP is a provider of payroll and human capital management solutions servicing the full scope of businesses from micro to global enterprises. ADP was established in 1949 and serves over 990,000 clients primarily in the United States. ADP's employer services segment offers payroll, HCM solutions, HR outsourcing, insurance and retirement services. The smaller but faster-growing PEO segment provides HR outsourcing solutions to small and midsize businesses through a co-employment model.
Read more on ADP →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →